Cellular and Cytokine Responses in the Circulation and Tissue Reactions in the Lung of Rhesus Monkeys (Macaca mulatta) Pretreated with Cyclosporin A and Challenged with Staphylococcal Enterotoxin B
Free accessOtherFirst published online April, 2001
Cellular and Cytokine Responses in the Circulation and Tissue Reactions in the Lung of Rhesus Monkeys (Macaca mulatta) Pretreated with Cyclosporin A and Challenged with Staphylococcal Enterotoxin B
Cyclosporin A (CsA), an inhibitor of T cell cytokine production, protects mice against staphylococca l enterotoxin B (SEB) intoxication. To determine whether CsA treatment would work in a species closer to humans, 4 rhesus monkeys were given 50 mg/kg CsA followed by an intratracheal challenge with approximately 6 LD50 of SEB. The CsA was not protective: one of the monkey s died and the other three had to be euthanized when they became moribund. All monkeys made IL-2, TNF, and IFN-γ in response to SEB. In addition, there was about a 10-fold increase in ACTH levels 2 hr after SEB challenge. CsA significantly suppressed in vitro proliferation of lymphocytes from treated monkeys. Both CsA-treated monkeys and monkeys that had been challenged in a previous experiment with a lethal dose of SEB but had received no cyclosporin had pathologic changes in several organs. The most prominent changes were marked edema and leukocytic infiltration of the bronchial and bronchiolar mucosa. The CsA treatment appeared to reduce the intensity of lung inflammation, but this effect was not sufficient to protect the monkeys. The results suggest that CsA alone may not be an effective therapeutic agent for humans suffering from SEB intoxication or gram-positive septic shock.
Barton BE, Shortall J., Jackson JV (1996). Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun64: 714—718.
2.
Bean AGD , Freiberg RA, Andrade S., Menon S., Zlotnik A. (1993). Interleukin 10 protects mice against staphylococca l enterotoxin B-induced lethal shock. Infect Immun61: 4937—4939.
3.
Beisel WR (1972). Pathophysiology of staphylococcal enterotoxin, type B, (SEB) toxemia after intravenous administration to monkeys. Toxicon10: 433—440.
4.
Belldegrun A. , Webb DE, Austin HA, Steinberg SM, White DE, Linehan WM, Rosenberg SA (1987). Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer . Ann Intern Med106: 817—822.
5.
Bergdoll MS (1970). Enterotoxins. In: Microbial Toxins , Vol. III. Bacterial Protein Toxins , Montie TC, Kadis S, Ajl SJ (eds). Academic Press, NY, pp 265—326.
6.
Bergdoll MS (1983). Enterotoxins. In: Staphylococci and Staphylococcal Infections, Vol. 2, Easmon CSF, Adlam C (eds). Academic Press, New York, pp 559—598.
7.
Bhatti AR, Micusan VV (1996). A mouse model for staphylococcal enterotoxins toxicity. Microbios86: 247—253.
8.
Billiau A. (1996). Interferon-γ: Biology and role in pathogenesis . Adv Immunol62: 61—130.
9.
Blank C., Luz A., Bendigs S., Erdmann A., Wagner H., Heeg K. ( 1997). Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol27: 825—833.
10.
Bohach GA, Fast DJ, Nelson RD, Schlievert PM (1990). Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol17: 251—272.
11.
Bolton C., Borel JF, Cuzner ML, Davison AN, Turner AM (1982). Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis. J NeurologicSci56: 147—153.
12.
Borel JF (1989). Pharmacology of cyclosporine (Sandimmune) IV. Pharmacological properties in vivo. Pharmacol Rev41: 259— 371.
13.
Bourrié B., Benoît J-M., Derocq J-M., Esclangon M., Thomas C., Le Fur G., Casellas P. (1996). A sigma ligand, SR31747A, potently modulates staphylococcal enterotoxin B-induced cytokine production in mice. Immunology88: 389—393.
14.
Chen JY-J , Qiao Y., Komisar JL, Baze WB, Hsu I-C., Tseng J. (1994). Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun62: 4626 — 4631.
15.
Cohen SBA , Parry SL, Feldmann M., Foxwell B. (1997). Autocrine and paracrine regulation of human T cell IL-10 production. J Immunol158: 5596—5602.
16.
Derynck R., Choy L. ( 1998). Transforming growth factor-β and its receptors. In: The Cytokine Handbook, 3rd ed., Thomson AW (ed). Academic Press, San Diego, pp 593—636.
17.
Di Padova FE (1989). Pharmacology of cyclosporine (Sandimmune) V. Pharmacological effects on immune function: In vitro studies. Pharmacol Rev41: 373—405.
18.
Evans SW, Whicher JT (1993). The cytokines: physiological and pathophysiological aspects. Adv Clin Chem30: 1—88.
19.
Florquin S., Aaldering L. (1997). Superantigens: A tool to gain new insight into cellular immunity. Res Immunol Inst Pasteur148: 373— 386.
20.
Florquin S., Amraoui Z., Abramowicz D., Goldman M. (1994). Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol153: 2618—2623.
21.
Florquin S., Amraoui Z., Dubois C., Decuyper J., Goldman M. (1994). The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med180: 1153— 1158.
22.
Florquin S., Amraoui Z., Goldman M. (1995). T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-γ and interleukin-10 secretion. Eur J Immunol25: 1148—1153.
23.
Florquin S., Goldman M. (1996). Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice. Infect Immun64: 3443—3445.
24.
Garvey MB, Black JM (1972). The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle. J Clin Pathol25: 680—682.
25.
Gaynor ER, Vitek L., Sticklin L., Creekmore SP, Ferraro ME, Thomas JX, Fisher SG, Fisher RI (1988). The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med109: 953—958.
26.
Gonzalo JA, González-García A., Martínez-A C., Kroemer G. (1993). Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J Exp Med177: 1239—1246.
27.
Guide for the Care and Use of Laboratory Animals. Department of Health and Human Services, Public Health Service, NIH Publication 86-23, Revised 1985. US Government Printing Office, Washington, DC.
28.
Hack CE, Aarden LA, Thijs LG (1997). Role of cytokines in sepsis. Adv Immunol66: 101—195.
29.
Hack CE, Ogilvie AC, Eisele B., Eerenberg AJM, Wagstaff J., Thijs LG (1993). C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med19: S19—S28.
30.
Haskó G., Virág L., Egnaczyk G., Salzman AL, Szabó C. (1998). The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B . Eur J Immunol28: 1417— 1425.
31.
Heeg K., Miethke T., Wagner H. (1996). Superantigen-mediated lethal shock: The functional state of ligand-reactive T cells. Curr Top Microbiol Immunol216: 83—100.
32.
Kotzin BL, Leung DYM, Kappler J., Marrack P. (1993). Superantigens and their potential role in human disease. Adv Immunol54: 99—166.
33.
Krakauer T. (1995). Differential inhibitory effects of interleukin-10, interleukin-4, and dexamethasone on staphylococcal enterotoxin-induced cytokine production and T cell activation. J Leukocyte Biol57: 450— 454.
34.
Krakauer T. , Pitt L., Hunt RE (1997). Detection of interleukin-6 and interleukin-2 in serum of rhesus monkeys exposed to a nonlethal dose of staphylococcal enterotoxin B. Mil Med162: 612—615.
35.
Kusnecov AW , Liang R., Shurin G. (1999). T-lymphocyte activation increases hypothalamic and amygdaloid expression of CRH mRNA and emotional reactivity to novelty. J Neurosci19: 4533—4543.
36.
Lang R., Wagner H., Heeg K. ( 1995). Differential effects of the immunosuppressive agents cyclosporine and leflunomide in vivo. Transplantation59: 382—389.
37.
LeClaire RD , Kell W., Bavari S., Smith TJ, Hunt RE (1996). Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicity. Toxicology107: 69—81.
38.
Lehmann V., Freudenberg MA, Galanos C.1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med165: 657—663.
39.
Marrack P., Blackman M., Kushnir E., Kappler J. (1990). The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med171:455—464.
40.
Matthys P., Mitera T., Heremans H., Van Damme J., Billiau A. (1995). Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun63: 1158— 1164.
41.
Mattix ME, Hunt RE, Wilhelmsen CL, Johnson AJ, Baze WB ( 1995). Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol23: 262— 268.
42.
Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer PH, Wagner H. (1992). T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J Exp Med175: 91—98.
43.
Mountz JD, Baker TJ, Borcherding DR, Bluethmann H., Zhou T., Edwards CK (1995). Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock. J Immunol155: 4829— 4837.
44.
Muraille E. , De Smedt T., Andris F., Pajak B., Armant M., Urbain J., Moser M., Leo O. (1997). Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by Vβ -unrestricted T cell unresponsivenes s and defective antigen-presenting cell functions. J Immunol158: 2638—2647.
45.
Nagaki M., Muto Y., Ohnishi H., Yasuda S., Sano K., Naito T., Maeda T., Yamada T., Moriwaki H. (1994). Hepatic injury and lethal shock in galactosaminesensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology106: 450—458.
46.
Pettit GW, Yamada T., Wing DA, Jahrling PB (1978). Enterotoxic shock in rhesus monkeys. The role of selected bloodborne factors. Circulation Res43:398—405.
47.
Physicians' Desk Reference. 54th ed. 2000. Montvale, NJMedical Economics Co.
48.
Roessler WG , Kautter DA (1962). Modification of the Henderson apparatus for studying air-borne infections. Evaluations using aerosols of Listeria monocytogenes. J Infect Dis110: 17—22.
49.
Sarawar SR, Blackman MA, Doherty PC (1994). Superantigen shock in mice with an inapparent viral infection. J Infect Dis170: 1189— 1194.
50.
Schantz EJ, Roessler WG, Wagman J., Spero L., Dunnery DA, Bergdoll MS (1965). Purification of staphylococcal enterotoxin B. Biochemistry4: 1011— 1016.
51.
Shin G-T., Khanna A., Ding R., Sharma VK, Lagman M., Li B., Suthanthiran M. (1998). In vivo expression of transforming growth factor-β 1 in humans. Stimulation by cyclosporine. Transplantation65: 313—318.
52.
Silverman SJ , Espeseth DA, Schantz EJ (1969). Effect of formaldehyde on the immunochemical and biological activity of staphylococcal enterotoxin B. J Bacteriol98: 437—442.
53.
Sugiyama H. , McKissic EM, Bergdoll MS, Heller B. (1964). Enhancement of bacterial endotoxin lethality by staphylococcal enterotoxin . J Infect Dis114: 111—118.
54.
Tseng J., Komisar JL, Chen JY-J, Hunt RE, Johnson AJ, Pitt L., Rivera J., Ruble DL, Trout R., Vega A. ( 1993). Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B. Infect Immun61: 391—398.
55.
Ulrich RG, Sidell S., Taylor TJ, Wilhelmsen CL, Franz DR (1997). Staphylococcal enterotoxin B and related pyrogeni c toxins. In: Textbook of Military Medicine. Part I. Warfare, Weaponry, and the Casualty, Zajtchuk R (ed). Office of the Surgeon General, Department of the Army, Washington, DC, pp 621—630
56.
Van Snick J. (1990). Interleukin-6: an overview . Annu Rev Immunol8: 253— 278.
57.
Wallach D., Holtmann H., Engelmann H., Nophar Y. (1988). Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. J Immunol140: 2994—2999.
58.
Weng C-F. (1994). Interactions of the immune and neuroendocrine systems in the response to the superantigen staphylococcal enterotoxin B. Ph.D. dissertation, University of Maryland.
59.
Weng C-F., Komisar JL, Hunt RE, Johnson AJ, Pitt ML, Ruble DL, Tseng J. (1997). Immediate responses of leukocytes, cytokines and glucocorticoid hormones in the blood circulation of monkeys following challenge with aerosolized staphylococca l enterotoxin B. Internat Immunol9: 1825 — 1836.
60.
Whiteside TL (1994). Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol14: 327— 339.
61.
Yan Z., Yang DCH, Neill R., Jett M. ( 1999). Production of tumor necrosis factor alpha in human T lymphocytes by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C. Infect Immun67: 6611—6618.
